Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study. [electronic resource]
Producer: 19990826Description: 250-7 p. digitalISSN:- 0030-3755
- Acute Disease
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents -- administration & dosage
- Anti-Infective Agents -- administration & dosage
- Bacteria -- drug effects
- Child
- Colony Count, Microbial
- Conjunctiva -- microbiology
- Conjunctivitis, Bacterial -- drug therapy
- Double-Blind Method
- Female
- Fluoroquinolones
- Follow-Up Studies
- Haemophilus Infections -- drug therapy
- Humans
- Male
- Middle Aged
- Ophthalmic Solutions
- Prospective Studies
- Quinolones -- administration & dosage
- Staphylococcal Infections -- drug therapy
- Streptococcal Infections -- drug therapy
- Tobramycin -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.